Overexpression of BCL2 , BCL6 , VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival.
Rafael CerónAdolfo Martínez-TovarChristian Omar Ramos-PeñafielAdrián De la Cruz RosasAnel Irais García LagunaIveth Mendoza SalasGoujon PalmerosEfreen Horacio Montaño FigueroaJuan José Navarrete-PérezSilvia Jiménez-MoralesCarlos Martinez MurrilloIrma Olarte CarrilloPublished in: OncoTargets and therapy (2022)
This study showed that in liquid biopsies analyzed, the presence of CTCs can be confirmed through molecular biomarkers, and it has an impact on OS and EFs, making this detection useful in the follow-up and prognosis of patients with DLBCL.